Ngā hua rapu - Gopalakrishna, Prashanth
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy mā Vahdat, Linda T., Garcia, Agustin A., Vogel, Charles, Pellegrino, Christine, Lindquist, Deborah L., Iannotti, Nicholas, Gopalakrishna, Prashanth, Sparano, Joseph A.
I whakaputaina 2013Text -
2
The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies mā Gupta, Vikas, Harrison, Claire, Hexner, Elizabeth O., Al-Ali, Haifa Kathrin, Foltz, Lynda, Montgomery, Michael, Sun, William, Gopalakrishna, Prashanth, Kantarjian, Hagop, Verstovsek, Srdan
I whakaputaina 2016Text -
3
Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses mā Verstovsek, Srdan, Gotlib, Jason, Mesa, Ruben A., Vannucchi, Alessandro M., Kiladjian, Jean-Jacques, Cervantes, Francisco, Harrison, Claire N., Paquette, Ronald, Sun, William, Naim, Ahmad, Langmuir, Peter, Dong, Tuochuan, Gopalakrishna, Prashanth, Gupta, Vikas
I whakaputaina 2017Text -
4
The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitini... mā McMullin, Mary Frances, Harrison, Claire N., Niederwieser, Dietger, Demuynck, Hilde, Jäkel, Nadja, Gopalakrishna, Prashanth, McQuitty, Mari, Stalbovskaya, Viktoriya, Recher, Christian, Theunissen, Koen, Gisslinger, Heinz, Kiladjian, Jean-Jacques, Al-Ali, Haifa-Kathrin
I whakaputaina 2015Text -
5
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis mā Vannucchi, Alessandro M., Kantarjian, Hagop M., Kiladjian, Jean-Jacques, Gotlib, Jason, Cervantes, Francisco, Mesa, Ruben A., Sarlis, Nicholas J., Peng, Wei, Sandor, Victor, Gopalakrishna, Prashanth, Hmissi, Abdel, Stalbovskaya, Viktoriya, Gupta, Vikas, Harrison, Claire, Verstovsek, Srdan
I whakaputaina 2015Text -
6
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study mā Ross, David M., Masszi, Tamas, Gómez Casares, María Teresa, Hellmann, Andrzej, Stentoft, Jesper, Conneally, Eibhlin, Garcia-Gutierrez, Valentin, Gattermann, Norbert, le Coutre, Philipp D., Martino, Bruno, Saussele, Susanne, Giles, Francis J., Radich, Jerald P., Saglio, Giuseppe, Deng, Weiping, Krunic, Nancy, Bédoucha, Véronique, Gopalakrishna, Prashanth, Hochhaus, Andreas
I whakaputaina 2018Text